327 related articles for article (PubMed ID: 16954221)
21. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies.
He Y
Adv Exp Med Biol; 2006; 581():539-42. PubMed ID: 17037594
[No Abstract] [Full Text] [Related]
22. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
[TBL] [Abstract][Full Text] [Related]
23. Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.
Yeung KS; Yamanaka GA; Meanwell NA
Med Res Rev; 2006 Jul; 26(4):414-33. PubMed ID: 16521129
[TBL] [Abstract][Full Text] [Related]
24. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
[TBL] [Abstract][Full Text] [Related]
25. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
26. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
Yi CE; Ba L; Zhang L; Ho DD; Chen Z
J Virol; 2005 Sep; 79(18):11638-46. PubMed ID: 16140741
[TBL] [Abstract][Full Text] [Related]
27. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
He Y; Li J; Heck S; Lustigman S; Jiang S
J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
Yan K; Tan W; Wang H; Wang Y; Zhang X; Li Y; Ruan L
Viral Immunol; 2009 Feb; 22(1):57-66. PubMed ID: 19210229
[TBL] [Abstract][Full Text] [Related]
29. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].
Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862
[TBL] [Abstract][Full Text] [Related]
30. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction.
Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY
Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697
[TBL] [Abstract][Full Text] [Related]
31. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.
Li W; Zhang C; Sui J; Kuhn JH; Moore MJ; Luo S; Wong SK; Huang IC; Xu K; Vasilieva N; Murakami A; He Y; Marasco WA; Guan Y; Choe H; Farzan M
EMBO J; 2005 Apr; 24(8):1634-43. PubMed ID: 15791205
[TBL] [Abstract][Full Text] [Related]
32. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.
Sui J; Li W; Murakami A; Tamin A; Matthews LJ; Wong SK; Moore MJ; Tallarico AS; Olurinde M; Choe H; Anderson LJ; Bellini WJ; Farzan M; Marasco WA
Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2536-41. PubMed ID: 14983044
[TBL] [Abstract][Full Text] [Related]
33. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
[TBL] [Abstract][Full Text] [Related]
34. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
35.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
36. Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.
Zhang X; Wang J; Wen K; Mou Z; Zou L; Che X; Ni B; Wu Y
Viral Immunol; 2009 Dec; 22(6):407-15. PubMed ID: 19951177
[TBL] [Abstract][Full Text] [Related]
37. Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients.
Cao Z; Liu L; Du L; Zhang C; Jiang S; Li T; He Y
Virol J; 2010 Nov; 7():299. PubMed ID: 21047436
[TBL] [Abstract][Full Text] [Related]
38. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
Liu L; Fang Q; Deng F; Wang H; Yi CE; Ba L; Yu W; Lin RD; Li T; Hu Z; Ho DD; Zhang L; Chen Z
J Virol; 2007 May; 81(9):4694-700. PubMed ID: 17314167
[TBL] [Abstract][Full Text] [Related]
39. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit.
Zeng F; Hon CC; Yip CW; Law KM; Yeung YS; Chan KH; Malik Peiris JS; Leung FC
FEBS Lett; 2006 Oct; 580(24):5612-20. PubMed ID: 16989815
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M
Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
